Showing results (361-370 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|August 12, 2008
Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease riskRodney R DietertCurrent Drug Safety|July 10, 2010
Safety of therapeutic monoclonal antibodiesRonald Niebecker, Charlotte KloftCurrent Drug Safety|July 10, 2010
The new patient and responsible self-medication practices: a critical reviewAlan TaleviCurrent Drug Safety|April 22, 2010
Restless leg syndrome associated with olanzapine: a case seriesShilpa Aggarwal, Seetald Dodd, Michael BerkCurrent Drug Safety|April 17, 2010
Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effectsCharles DeBattista, Kristina DeBattistaCurrent Drug Safety|June 19, 2009
The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screeningLeslie A Linares, Beatrice A Golomb, Joyce A Jaojoco, et al.Current Drug Safety|June 19, 2009
Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medicationsLeslie CitromeCurrent Drug Safety|June 19, 2009
Adverse effects of statins - mechanisms and consequencesJerzy Bełtowski, Grazyna Wójcicka, Anna Jamroz-WiśniewskaCurrent Drug Safety|January 20, 2009
A multiple-dose, open-label, safety, compliance, and usage evaluation study of epicutaneously applied Diractin (ketoprofen in Transfersome) in joint/musculoskeletal pain or soft tissue inflammationWerner Kneer, Ilka Rother, Matthias Rother, et al.Pageof 98